14.8 0.11 (0.75%) | 04-22 13:08 | |||||||||||||
|
|
Short term | ![]() ![]() ![]() |
|||
Mid term | ![]() ![]() ![]() |
|||
Targets | 6-month : | 18.14 | 1-year : | 19.35 |
Resists | First : | 15.53 | Second : | 16.56 |
Pivot price | 15 ![]() |
|||
Supports | First : | 13.86 | Second : | 11.53 |
MAs | MA(5) : | 14.94 ![]() |
MA(20) : | 15.25 ![]() |
MA(100) : | 17.14 ![]() |
MA(250) : | 16.65 ![]() |
|
MACD | MACD : | -0.5 ![]() |
Signal : | -0.5 ![]() |
%K %D | K(14,3) : | 48.2 ![]() |
D(3) : | 51.7 ![]() |
RSI | RSI(14): 40.7 ![]() |
|||
52-week | High : | 18.84 | Low : | 13.86 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.[ EKG ] has closed above bottom band by 37.8%. Bollinger Bands are 1.2% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
If tomorrow: | Open lower | Open higher |
High: | 15.19 - 15.3 | 15.3 - 15.38 |
Low: | 14.28 - 14.42 | 14.42 - 14.53 |
Close: | 14.49 - 14.69 | 14.69 - 14.83 |
The fund will normally invest at least 80% of its net assets (plus any borrowings for investment purposes) in the common stocks and depositary receipts that comprise the index. The index is designed to measure the performance of a selection of companies that are primarily engaged in and involved at the intersection of healthcare and technology, as classified by Lux Capital based on analysis of the products and services offered by those companies. The fund is non-diversified.
Tue, 22 Apr 2025
How To Trade (EKG) - news.stocktradersdaily.com
Mon, 07 Apr 2025
Qiagen Shares Rise Premarket As Preliminary Q1 Results, Hikes FY25 EPS Guidance - Benzinga
Sun, 06 Apr 2025
How to Take Advantage of moves in (EKG) - news.stocktradersdaily.com
Fri, 14 Feb 2025
Dexcom Q4 Earnings: Expanding Sales, New Products, Margin Pressure And More - Benzinga
Sun, 26 Jan 2025
Remote Work Vs. Return-To-Office: Can Veeva's Flexibility Outshine JPMorgan's Office Mandate? - Benzinga
Sun, 15 May 2022
IQVIA: A Leading Digital Healthcare Stock - Nanalyze
Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
Exchange:
NASDAQ
|
|
Sector:
Financial Services
|
|
Industry:
Asset Management
|
|
Shares Out | 0 (M) |
Shares Float | 0 (M) |
Held by Insiders | 0 (%) |
Held by Institutions | 0 (%) |
Shares Short | 0 (K) |
Shares Short P.Month | 0 (K) |
EPS | 0 |
EPS Est Next Qtrly | 0 |
EPS Est This Year | 0 |
EPS Est Next Year | 0 |
Book Value (p.s.) | 0 |
Profit Margin | 0 % |
Operating Margin | 0 % |
Return on Assets (ttm) | 0 % |
Return on Equity (ttm) | 0 % |
Qtrly Rev. Growth | 0 % |
Gross Profit (p.s.) | 0 |
Sales Per Share | 0 |
EBITDA (p.s.) | 0 |
Qtrly Earnings Growth | 0 % |
Operating Cash Flow | 0 (M) |
Levered Free Cash Flow | 0 (M) |
PE Ratio | 0 |
PEG Ratio | 0 |
Price to Book value | 0 |
Price to Sales | 0 |
Price to Cash Flow | 0 |
Dividend | 0 |
Forward Dividend | 0 |
Dividend Yield | 0% |
Dividend Pay Date | Invalid DateTime. |
Ex-Dividend Date | Invalid DateTime. |